NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells

Abstract 1: Loss of STAT1 predicts outcome in prostate cancer patients at diagnosis by regulating the proliferation of prostate epithelial cells.

(2014) Sophia Hatziieremia et al.   CANCER RESEARCH

SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization

(2013) P. Yi et al.   GENES & DEVELOPMENT

T antigen transformation reveals Tp53/RB-dependent route to PLAC1 transcription activation in primary fibroblasts

(2013) Y Chen et al.   Oncogenesis

Steroid receptor coactivator-3 as a potential molecular target for cancer therapy

(2012) Jean Ching-Yi Tien et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Plac1 (placenta-specific 1) is essential for normal placental and embryonic development

(2012) Suzanne M. Jackman et al.   MOLECULAR REPRODUCTION AND DEVELOPMENT

RXRα and LXR activate two promoters in placenta- and tumor-specific expression of PLAC1

(2011) Y. Chen et al.   PLACENTA

The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer

(2009) Tyler Lahusen et al.   BREAST CANCER RESEARCH AND TREATMENT

Selective Activation of Trophoblast-specificPLAC1in Breast Cancer by CCAAT/Enhancer-binding Protein β (C/EBPβ) Isoform 2

(2009) Michael Koslowski et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The role of SRC-3 in human breast cancer

(2009) Ondrej Gojis et al.   Nature Reviews Clinical Oncology

Steroid Receptor Coactivator-3/AIB1 Promotes Cell Migration and Invasiveness through Focal Adhesion Turnover and Matrix Metalloproteinase Expression

(2008) J. Yan et al.   CANCER RESEARCH

Unique Roles of p160 Coactivators for Regulation of Breast Cancer Cell Proliferation and Estrogen Receptor-α Transcriptional Activity

(2008) Sudipan Karmakar et al.   ENDOCRINOLOGY